News

The collaboration provides VedaBio access to essential CRISPR IP, accelerating the development of customised diagnostic ...
Researchers have developed a new AI tool to help scientists plan gene-editing experiments. "CRISPR-GPT" can help generate ...
Tulane University researchers have developed an enhanced CRISPR-based tuberculosis test that works with a simple tongue swab, ...
Schematic illustration of nucleic acid detection by the conventional CRISPR assay and the asymmetric CRISPR assay. Credit: Nature Communications (2023). DOI: 10.1038/s41467-023-43389-7 Changchun Liu, ...
The new system developed by Professor Chad Mirkin delivers CRISPR machinery more safely and effectively into cells.
VedaBio, a pioneering biotechnology company transforming molecular detection, today announced a non-exclusive license agreement with Mammoth Biosciences, Inc. for the use of select CRISPR-based ...
Originally developed for gene editing, CRISPR-Cas systems have now become powerful molecular diagnostic tools. However, their widespread adoption in diagnostics has relied heavily on traditional ...
Coronavirus Disease 2019 (COVID-19) has driven the use of nucleic acid testing technology in clinical testing. There is a growing need for point-of-care testing (POCT) devices that can integrate ...
The COVID pandemic was a make or break moment for many a biotech. At Mammoth Biosciences, it may have been a little of both. For Janice Chen, Ph.D., the CRISPR biotech's chief technology officer and ...
When brain development gets off to a bad start, the consequences are lifelong. One example is a condition called SCN2A ...
A CRISPR mouth-swab test could transform TB screening with rapid, low-cost detection in low-resource and asymptomatic cases.